There are 3 key considerations in understanding 340B program results and benefits.
Andrew L. Wilson, PharmD, FASHP
Advertisement
Andrew L. Wilson, PharmD, FASHP, is vice president of 340B solutions, McKesson.
Articles by Andrew L. Wilson, PharmD, FASHP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacists Can Play Central Role in Patients’ Infusion Services | ASHP Midyear 2025
2
Women Seek Holistic Interventions for Improving Health Outcomes
3
What TrumpRx Means for Independent Pharmacies and Their Patients
4
Social and Economic Factors Significantly Influence Supply of OTC Antibiotics
5
